Impact of induction chemotherapy and socioeconomics on sinonasal undifferentiated carcinoma survival.
Brandon M LehrichKhodayar GoshtasbiArash AbiriTyler YasakaRonald SahyouniPeter PapagiannopoulosBobby A TajudeenEdward Cheng-Lung KuanPublished in: International forum of allergy & rhinology (2020)
In this SNUC population-based analysis, IC did not appear to provide additional OS benefit regardless of disease stage or timing before definitive treatment. Distance to treatment and level of comorbidities may be associated with receiving IC, whereas type of insurance and residence education level may impact SNUC OS, regardless of treatment.